TransMedics enters $60M CIBC term loan facility, repays $35M OrbiMed debt

TransMedics Group, Inc.

New $60M senior secured term loan borrowed in full on July 25, 2022, maturing in 5 years.
Proceeds repaid $35M outstanding under OrbiMed credit agreement; balance for general corporate purposes.
Interest at SOFR (floor 1.5%) + 2.00% or ABR + 1.00%, at company's option.
Financial covenants require minimum liquidity (greater of $10M or trailing 4-month EBITDA burn) and minimum total net revenue (75% of plan).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.